Search results for: 'system cell therapy market global'

The accelerating transition to net-zero emissions and demand for high-efficiency renewable energy are driving the need for photovoltaic technologies that surpass the performance limits of conventional crystalline silicon solar cells. As single-junction crystalline silicon solar cells approach their practical efficiency limits, perovskite-silicon ta...

This research service studies the Indian Diabetes market. It provides the number of Type 1 and Type 2 diabetic patients in India across different age groups and forecasts these numbers up to 2030. It provides a detailed analysis of the two major segments of the market, the insulin market segment and the anti-diabetic medications segment, which incl...

16 Nov 2017  |  North America  |  Market Research

Global Executive Analysis of the Fuel Cell Passenger Car Market, Forecast to 2030

Fuel Cell Technology Development and Optimisation to be Heavily Driven by Incentives and Investments

Infographics

×

Research Scope: The research focuses on the legislative measures that have been taken by the Government globally to implement and adopt fuel cell vehicles and bring in new business models for private and public sectors to develop the hydrogen fuel stations across the world. Private and public sectors have constantly provided investments and funding...

02 Sep 2015  |  Global  |  Market Research

The New Age of Regenerative Medicine

Why Stem Cell Therapy?

Infographics

×

Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases suc...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

24 Jan 2022  |  Global  |  Market Research

Global X-ray Inspection Systems Growth Opportunities

Industry 4.0 and Compliance with Highly Demanding Standards Create New Opportunities for Innovation in Non-Destructive Industrial Inspection

Infographics

×

The global x-ray inspection system market is forecast to register an approximate 9.6% CAGR from 2021 to 2026. The report follows a specific methodology that includes discussions with senior management of x-ray inspection system manufacturers supported by secondary research. The x-ray inspection systems market, generating $276.2 million in 2...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...